Filgrastim biosimilar (Hospira)

非格司亭生物类似药（Hospira）

Report date: 2024/04/29 11:24:41

Base Information

Drug NameFilgrastim biosimilar (Hospira)
Drug Alias NamerhG-CSF (Hospira)非格司亭生物仿制药（Hospira）重组人粒细胞刺激因子（Hospira）Recombinant human granulocyte macrophage colony stimulating factor (Hospira)Filgrastim-aafi +[8] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsFebrile NeutropeniaNeutropeniaNeoplasms +[4] 
Global Approved IndicationsFebrile NeutropeniaNeutropeniaNeoplasms +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2010/06/07
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHospira
China Registration ClassN/A

Develop Information

Active CompaniesHospira IncPfizer Europe Ma Eeig
Inactive CompaniesHospiraPfizer Inc
Active IndicationsFebrile NeutropeniaNeutropeniaNeoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A